Barely Significant
← all excerpts

Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: <i>In vitro</i> and <i>in vivo</i> insights into therapeutic targeting.

iScience · 2026 · PMC13316217 · PMID 42383006

Europe PMCDOI
1
hedged sentence
0.0018
closest p · 0.0× alpha
0.0018
boldest claim

The sentences

showed a trendp = 0.0018actually significant
Enzymatic activity assays for SPHK1/2 showed a trend toward reduced activity ( Figure 1 D, p = 0.0018), indicating a decrease in both expression and activity of SPHK in human FRDA fibroblast cell lines.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.